Trial Profile
Effect of Influenza A/H1N1 2009 vaccine on immunogenicity between healthy volunteers, chronic renal failure patients, kidney transplant recipients and human immuno-deficiency virus infected patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Dec 2015
Price :
$35
*
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Pharmacodynamics
- 29 Dec 2015 New trial record